|
Real-time Estimate
Cboe BZX
11:06:14 2026-10-20 am EDT
|
5-day change | 1st Jan Change | ||
| 162.52 USD | +4.30% |
|
+2.40% | -12.36% |
| Oct. 14 | Axsome Shows Valuation Disconnect Ahead of Q3, RBC Says | MT |
| Oct. 08 | RBC Trims Price Target on Axsome Therapeutics to $295 From $297, Keeps Outperform Rating | MT |
| Market Cap | 8.16B 7.28B 6.74B 6.13B 11.5B 774B 11.69B 80.83B 31.79B 404B 30.62B 29.98B 1,293B | P/E 2026 * |
-53.9x | P/E 2027 * | 37.9x |
|---|---|---|---|---|---|
| Enterprise Value | 8.01B 7.14B 6.62B 6.02B 11.29B 760B 11.48B 79.37B 31.21B 397B 30.07B 29.44B 1,269B | EV / Sales 2026 * |
8.41x | EV / Sales 2027 * | 5.1x |
| Free-Float |
84.69% | Yield 2026 * |
-
| Yield 2027 * | - |
| Markets | Quality | ||
|---|---|---|---|
Nasdaq
| AXSM | Delayed | |
CBOE
| AXSM | Real-time | |
|
Tradegate
| 19X | Real-time | |
|
London S.E.
| 0HKF | Delayed | |
|
Börse Stuttgart
| 19X | Delayed | |
|
Boerse Muenchen
| 19X | Real-time | |
|
Deutsche Boerse AG
| 19X | Delayed | |
|
Borsa Italiana
| 1AXSM | End-of-day quote | |
|
Xetra
| 19X | Delayed |
Last Transcript: Axsome Therapeutics, Inc.
| 1 day | +2.35% | ||
| 1 week | +2.64% | ||
| Current month | -12.99% | ||
| 1 month | -21.92% | ||
| 3 months | -27.61% | ||
| 6 months | -14.97% | ||
| Current year | -12.15% |
| 1 week | 154.5 |  | 169.96 |
| 1 month | 154.5 | | 210.85 |
| Current year | 152.28 | | 260.19 |
| 1 year | 123.5 | | 260.19 |
| 3 years | 55.02 | | 260.19 |
| 5 years | 20.63 | | 260.19 |
| 10 years | 1.94 | | 260.19 |
| Manager | Title | Age | Since |
|---|---|---|---|
| Chief Executive Officer | 57 | 2012-01-11 | |
Nick Pizzie
DFI | Director of Finance/CFO | 51 | 2018-05-15 |
Mark Jacobson
COO | Chief Operating Officer | 42 | 2014-03-31 |
| Director | Title | Age | Since |
|---|---|---|---|
| Chairman | 57 | 2012-01-11 | |
Roger Jeffs
BRD | Director/Board Member | 64 | 2014-11-30 |
Mark Coleman
BRD | Director/Board Member | 58 | 2014-11-30 |
| Date | Insider | Type | Main position | Quantity | % Market Cap. | Importance |
|---|---|---|---|---|---|---|
| 9/3/26 | Exercice | Chief Operating Officer | 30,000 | 0.0573% | ||
| 8/6/26 | Exercice | Chief Executive Officer | 13,980 | 0.0272% | ||
| 7/1/26 | Exercice | Chief Executive Officer | 148,998 | 0.2895% |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | +2.77% | +2.64% | +21.92% | +149.72% | 8.16B | |
| +4.73% | +11.45% | +60.71% | +122.37% | 1,106B | |
| +2.16% | +4.57% | +34.20% | +69.92% | 612B | |
| +2.16% | +5.17% | +24.34% | +97.32% | 500B | |
| +2.29% | +7.95% | +38.17% | +62.51% | 367B | |
| +3.31% | +4.78% | +72.34% | +44.89% | 354B | |
| +1.31% | +5.48% | +20.84% | +48.40% | 286B | |
| +1.27% | +5.63% | +0.02% | +20.48% | 256B | |
| +2.46% | +5.37% | +43.40% | +56.02% | 230B | |
| +1.85% | +5.99% | +27.35% | +101.51% | 190B | |
| Average | +2.34% | +1.30% | +34.33% | +77.31% | 390.83B | |
| Weighted average by Cap. | +2.83% | +2.28% | +41.23% | +81.36% |
| 2026 * | 2027 * | |
|---|---|---|
| Net sales | 953M 849M 787M 715M 1.34B 90.31B 1.36B 9.43B 3.71B 47.2B 3.57B 3.5B 151B | 1.52B 1.35B 1.25B 1.14B 2.14B 144B 2.17B 15.04B 5.91B 75.25B 5.7B 5.58B 241B |
| Net income | -152M -135M -125M -114M -214M -14.41B -218M -1.51B -592M -7.53B -570M -558M -24.07B | 222M 198M 183M 166M 312M 21.01B 317M 2.2B 863M 10.98B 832M 814M 35.11B |
| Net Debt | -148M -132M -122M -111M -208M -13.99B -211M -1.46B -575M -7.31B -554M -542M -23.38B | -421M -375M -348M -316M -593M -39.91B -603M -4.17B -1.64B -20.86B -1.58B -1.55B -66.69B |
| Date | Price | Change | Volume |
|---|---|---|---|
| 26-10-20 | $163.21 | +4.75% | 141,634 |
| 26-10-19 | $155.81 | -0.85% | 781,732 |
| 26-10-16 | $157.14 | -2.87% | 873,152 |
| 26-10-15 | $161.79 | -0.27% | 802,617 |
| 26-10-14 | $162.22 | +3.77% | 893,237 |
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite) and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be carried out. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of rankings based on the following ratings: Returns (Composite), Profitability (Composite) and Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully read the associated descriptions.
ESG MSCI
The MSCI ESG score assesses a company’s environmental, social, and governance practices relative to its industry peers. Companies are rated from CCC (laggard) to AAA (leader). This rating helps investors incorporate sustainability risks and opportunities into their investment decisions.
Quarterly revenue - Rate of surprise
- Stock Market
- Stocks
- AXSM Stock
Select your edition
All financial news and data tailored to specific country editions
